Cargando…

Comparison of Multiparametric Magnetic Resonance Imaging and Gallium-68 Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Detecting Carcinoma Prostate in Patients with Serum Prostate-Specific Antigen between 4 and 20 ng/ml

INTRODUCTION: We carried out this study to compare the diagnostic accuracy of multiparametric magnetic resonance imaging (mpMRI) and gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography (Ga-68 PSMA PET/CT) to detect prostatic carcinoma in patients with serum...

Descripción completa

Detalles Bibliográficos
Autores principales: Soni, Brijesh Kumar, Verma, Priyanka, Shah, Amit Kumar, Singh, Rajendra, Sonawane, Sunita, Asopa, Ramesh V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481845/
https://www.ncbi.nlm.nih.gov/pubmed/34658547
http://dx.doi.org/10.4103/ijnm.ijnm_243_20
_version_ 1784576771943825408
author Soni, Brijesh Kumar
Verma, Priyanka
Shah, Amit Kumar
Singh, Rajendra
Sonawane, Sunita
Asopa, Ramesh V.
author_facet Soni, Brijesh Kumar
Verma, Priyanka
Shah, Amit Kumar
Singh, Rajendra
Sonawane, Sunita
Asopa, Ramesh V.
author_sort Soni, Brijesh Kumar
collection PubMed
description INTRODUCTION: We carried out this study to compare the diagnostic accuracy of multiparametric magnetic resonance imaging (mpMRI) and gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography (Ga-68 PSMA PET/CT) to detect prostatic carcinoma in patients with serum prostate-specific antigen (PSA) between 4 and 20 ng/ml in prebiopsy setting. MATERIALS AND METHODS: This prospective study evaluated men with serum PSA values between 4 and 20 ng/ml. All patients underwent mpMRI and Ga-68 PSMA PET/CT, followed by 12-core transrectal ultrasonography (TRUS)-guided biopsy to detect prostatic carcinoma. The diagnostic accuracy of mpMRI and PSMA PET/CT scan was compared with histopathological findings. RESULTS: There were thirty patients included in the study with a median age of 73 years (age range: 69–79 years). The median total serum PSA was 8.0 ng/ml (5.0–19.9 ng/ml). Of these, 18 had an identifiable lesion on imaging and had histopathological findings suggestive of carcinoma prostate. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of mpMRI were 100%, 92.30%, 94.73%, and 100%, respectively, and that of PSMA PET scan were 94.44%, 100%, 100%, and 92.31%, respectively. The diagnostic accuracy of both was 96.67%. CONCLUSION: PSMA PET scan showed higher PPV and specificity while mpMRI showed higher sensitivity and NPV. The accuracy in predicting presence of carcinoma was the same for both. PSMA PET showed higher specificity and PPV and predicted the subsequent need of biopsy. In our study, the NPV of PET, though good, was lower than mpMRI. Prospective trials with larger sample size are needed. In combination, PET/MRI may achieve greater accuracy and may serve as investigation of choice.
format Online
Article
Text
id pubmed-8481845
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-84818452021-10-14 Comparison of Multiparametric Magnetic Resonance Imaging and Gallium-68 Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Detecting Carcinoma Prostate in Patients with Serum Prostate-Specific Antigen between 4 and 20 ng/ml Soni, Brijesh Kumar Verma, Priyanka Shah, Amit Kumar Singh, Rajendra Sonawane, Sunita Asopa, Ramesh V. Indian J Nucl Med Original Article INTRODUCTION: We carried out this study to compare the diagnostic accuracy of multiparametric magnetic resonance imaging (mpMRI) and gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography (Ga-68 PSMA PET/CT) to detect prostatic carcinoma in patients with serum prostate-specific antigen (PSA) between 4 and 20 ng/ml in prebiopsy setting. MATERIALS AND METHODS: This prospective study evaluated men with serum PSA values between 4 and 20 ng/ml. All patients underwent mpMRI and Ga-68 PSMA PET/CT, followed by 12-core transrectal ultrasonography (TRUS)-guided biopsy to detect prostatic carcinoma. The diagnostic accuracy of mpMRI and PSMA PET/CT scan was compared with histopathological findings. RESULTS: There were thirty patients included in the study with a median age of 73 years (age range: 69–79 years). The median total serum PSA was 8.0 ng/ml (5.0–19.9 ng/ml). Of these, 18 had an identifiable lesion on imaging and had histopathological findings suggestive of carcinoma prostate. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of mpMRI were 100%, 92.30%, 94.73%, and 100%, respectively, and that of PSMA PET scan were 94.44%, 100%, 100%, and 92.31%, respectively. The diagnostic accuracy of both was 96.67%. CONCLUSION: PSMA PET scan showed higher PPV and specificity while mpMRI showed higher sensitivity and NPV. The accuracy in predicting presence of carcinoma was the same for both. PSMA PET showed higher specificity and PPV and predicted the subsequent need of biopsy. In our study, the NPV of PET, though good, was lower than mpMRI. Prospective trials with larger sample size are needed. In combination, PET/MRI may achieve greater accuracy and may serve as investigation of choice. Medknow Publications & Media Pvt Ltd 2021 2021-09-23 /pmc/articles/PMC8481845/ /pubmed/34658547 http://dx.doi.org/10.4103/ijnm.ijnm_243_20 Text en Copyright: © 2021 Indian Journal of Nuclear Medicine https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Soni, Brijesh Kumar
Verma, Priyanka
Shah, Amit Kumar
Singh, Rajendra
Sonawane, Sunita
Asopa, Ramesh V.
Comparison of Multiparametric Magnetic Resonance Imaging and Gallium-68 Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Detecting Carcinoma Prostate in Patients with Serum Prostate-Specific Antigen between 4 and 20 ng/ml
title Comparison of Multiparametric Magnetic Resonance Imaging and Gallium-68 Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Detecting Carcinoma Prostate in Patients with Serum Prostate-Specific Antigen between 4 and 20 ng/ml
title_full Comparison of Multiparametric Magnetic Resonance Imaging and Gallium-68 Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Detecting Carcinoma Prostate in Patients with Serum Prostate-Specific Antigen between 4 and 20 ng/ml
title_fullStr Comparison of Multiparametric Magnetic Resonance Imaging and Gallium-68 Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Detecting Carcinoma Prostate in Patients with Serum Prostate-Specific Antigen between 4 and 20 ng/ml
title_full_unstemmed Comparison of Multiparametric Magnetic Resonance Imaging and Gallium-68 Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Detecting Carcinoma Prostate in Patients with Serum Prostate-Specific Antigen between 4 and 20 ng/ml
title_short Comparison of Multiparametric Magnetic Resonance Imaging and Gallium-68 Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Detecting Carcinoma Prostate in Patients with Serum Prostate-Specific Antigen between 4 and 20 ng/ml
title_sort comparison of multiparametric magnetic resonance imaging and gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography for detecting carcinoma prostate in patients with serum prostate-specific antigen between 4 and 20 ng/ml
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481845/
https://www.ncbi.nlm.nih.gov/pubmed/34658547
http://dx.doi.org/10.4103/ijnm.ijnm_243_20
work_keys_str_mv AT sonibrijeshkumar comparisonofmultiparametricmagneticresonanceimagingandgallium68prostatespecificmembraneantigenpositronemissiontomographycomputedtomographyfordetectingcarcinomaprostateinpatientswithserumprostatespecificantigenbetween4and20ngml
AT vermapriyanka comparisonofmultiparametricmagneticresonanceimagingandgallium68prostatespecificmembraneantigenpositronemissiontomographycomputedtomographyfordetectingcarcinomaprostateinpatientswithserumprostatespecificantigenbetween4and20ngml
AT shahamitkumar comparisonofmultiparametricmagneticresonanceimagingandgallium68prostatespecificmembraneantigenpositronemissiontomographycomputedtomographyfordetectingcarcinomaprostateinpatientswithserumprostatespecificantigenbetween4and20ngml
AT singhrajendra comparisonofmultiparametricmagneticresonanceimagingandgallium68prostatespecificmembraneantigenpositronemissiontomographycomputedtomographyfordetectingcarcinomaprostateinpatientswithserumprostatespecificantigenbetween4and20ngml
AT sonawanesunita comparisonofmultiparametricmagneticresonanceimagingandgallium68prostatespecificmembraneantigenpositronemissiontomographycomputedtomographyfordetectingcarcinomaprostateinpatientswithserumprostatespecificantigenbetween4and20ngml
AT asoparameshv comparisonofmultiparametricmagneticresonanceimagingandgallium68prostatespecificmembraneantigenpositronemissiontomographycomputedtomographyfordetectingcarcinomaprostateinpatientswithserumprostatespecificantigenbetween4and20ngml